Formosa Pharmaceuticals Inc (6838)

Currency in TWD
22.45
-0.50(-2.18%)
Closed·
Trading near 52-week Low
6838 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.4022.90
52 wk Range
22.4034.00
Key Statistics
Bid/Ask
22.40 / 22.55
Prev. Close
22.95
Open
22.85
Day's Range
22.4-22.9
52 wk Range
22.4-34
Volume
187.63K
Average Volume (3m)
156.44K
1-Year Change
-31.7629%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6838 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Earnings

Latest Release
Jun 03, 2026
EPS / Forecast
-0,10 / --
Revenue / Forecast
45,42M / --
EPS Revisions
Last 90 days

6838 Income Statement

Compare 6838 to Peers and Sector

Metrics to compare
6838
Peers
Sector
Relationship
P/E Ratio
−18.0x37.4x−0.3x
PEG Ratio
0.090.050.00
Price/Book
2.5x3.9x2.6x
Price / LTM Sales
64.9x5.4x3.1x
Upside (Analyst Target)
-1.0%49.0%
Fair Value Upside
Unlock−13.9%6.3%Unlock

Formosa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing TSY-110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002 to treat infectious eye diseases, such as conjunctivitis, keratitis, blepharitis, and meibomian gland dysfunction; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorectal cancer. It has a strategic partnership with Eyenovia, Inc. for the development of novel ophthalmic therapeutic; and Singapore Eye Research Institute to develop ophthalmic formulations for corneal diseases. Formosa Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Taipei City, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
69,67K0,05%1,60M
Other Institutional Investors
85,30M56,50%1,96B
Public Companies & Retail Investors
65,61M43,45%1,51B
Total
150,98M100,00%3,46B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Formosa Laboratories, Inc.40,66%61 387 6531 408 847
CDIB Capital Management Corporation3,98%6 003 653137 784

FAQ

What Is the Formosa Pharmaceuticals (6838) Stock Price Today?

The Formosa Pharmaceuticals stock price today is 22,45 TWD.

What Stock Exchange Does Formosa Pharmaceuticals Trade On?

Formosa Pharmaceuticals is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for Formosa Pharmaceuticals?

The stock symbol for Formosa Pharmaceuticals is "6838."

What Is the Formosa Pharmaceuticals Market Cap?

As of today, Formosa Pharmaceuticals market cap is 3,39B TWD.

What Is Formosa Pharmaceuticals's Earnings Per Share (TTM)?

The Formosa Pharmaceuticals EPS (TTM) is -1,25.

From a Technical Analysis Perspective, Is 6838 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Formosa Pharmaceuticals Stock Split?

Formosa Pharmaceuticals has split 0 times.

What is the current trading status of Formosa Pharmaceuticals (6838)?

As of Aug 18, 2026, Formosa Pharmaceuticals (6838) is trading at a price of 22,45 TWD, with a previous close of 22,95 TWD. The stock has fluctuated within a day range of 22,40 TWD to 22,90 TWD, while its 52-week range spans from 22,40 TWD to 34,00 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.